Preferred Label : mitapivat;

MeSH synonym : N-(4-((4-(Cyclopropylmethyl)-1-piperazinyl)carbonyl)phenyl)-8-quinolinesulfonamide; N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide; 8-Quinolinesulfonamide, N-(4-((4-(cyclopropylmethyl)-1-piperazinyl)carbonyl)phenyl)-;

MeSH hyponym : mitapivat hemisulfate sesquihydrate;

MeSH Related Number : N4JTA67V3O;

UNII : 2WTV10SIKH;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/pyrukynd
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
drug approval
europe
mitapivat
mitapivat
mitapivat
pyruvate kinase deficiency of red cells
administration, oral
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
Nous contacter.
20/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.